Russell Investments Group
ATNM icon

Russell Investments Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Russell Investments Group’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,340
Closed -$18.1K – 4239
2025
Q4 		$18.1K Hold
13,340
– – ﹤0.01% 3653
2025
Q3 		$21.3K Sell
13,340
-416
-3% -$678 ﹤0.01% 3576
2025
Q2 		$19.3K Sell
13,756
-853
-6% -$1.28K ﹤0.01% 3201
2025
Q1 		$23.5K Buy
14,609
+10,435
+250% +$13.2K ﹤0.01% 3076
2024
Q4 		$5.26K Sell
4,174
-294
-7% -$456 ﹤0.01% 3273
2024
Q3 		$8.4K Buy
4,468
+4,002
+859% +$15.8K ﹤0.01% 3123
2024
Q2 		$3.45K Buy
+466
New +$3.84K ﹤0.01% 3285
2023
Q4 		– Sell
-39
Closed -$231 – 3212
2023
Q3 		$231 Buy
+39
New +$260 ﹤0.01% 3472
2020
Q4 		– Sell
-9,200
Closed -$89K – 3036
2020
Q3 		$89K Sell
9,200
-15,557
-63% -$172K ﹤0.01% 2999
2020
Q2 		$261K Buy
+24,757
New +$188K ﹤0.01% 2620

Other funds holding ATNM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's ATNM Position: Q1 2026 in Review

Russell Investments Group sold out of Actinium Pharmaceuticals (ATNM) in Q1 2026, closing a stake of 13,340 shares — an estimated $18.1K sold.

Russell Investments Group first reported a position in ATNM in Q2 2020 and held it in 10 quarters. The position peaked at $261K in Q2 2020. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.

  • Russell Investments Group reported no remaining Actinium Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 13,340 Actinium Pharmaceuticals shares in Q1 2026, an estimated $18.1K.
  • Russell Investments Group first reported a position in Actinium Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • Russell Investments Group's Actinium Pharmaceuticals position peaked at $261K in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.